Navigation Links
MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
Date:9/6/2007

Tuesday, September 11, 2007 - 11:00 a.m. ET; 8:00 a.m. PT

VANCOUVER and SAN DIEGO, CA, Sept. 6 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, will host a conference call and webcast on Tuesday, September 11, 2007 at 11:00 a.m. ET (8:00 a.m. PT) to discuss financial results for the first fiscal quarter ended July 31, 2007. An update on company activities will also be provided. To participate in the conference call, please dial 416-644-3415 or 1-800-732-9303. The call will be available for replay until September 25, 2007 by calling 416-640-1917 or 1-877-289-8525 and entering the pass code 21244947 followed by the number sign. The live and archived webcast can be accessed through the company's website at http://www.migenix.com for the next 90 days.

MIGENIX will also be hosting its 2007 Annual General Meeting of the shareholders of the Company on Monday, September 10, 2007 at 2:00 p.m. Pacific Time at the BC Research Complex, Auditorium, 3650 Wesbrook Mall, Vancouver, British Columbia.

About MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs primarily in the area of infectious diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C infections (Phase II and preclinical), the prevention of catheter-related infections (Phase III) and the treatment of dermatological diseases (Phase II). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. Additional information can be found at http://www.migenix.com.

"Jim DeMesa"

James M. DeMesa, M.D.

President & CEO

CONTACT: Art Ayres, MIGENIX Inc., Tel: (604) 221-9666 Ext. 233, aayres@migenix.com; Dian Griesel, Ph.D., Inves
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Midwest life science stocks sizzle in a tepid first quarter
3. Morgridge Institute for Research seeks first CEO
4. Sonic Foundry reports first cash-positive quarter
5. Angel investors commit $12.7B in first half of `06
6. Aurora team implants Wisconsins first total artificial heart
7. First half of 2006 roundup: Big Pharma trumps biotech
8. GE announces first installation of Discovery VCT
9. GE Healthcare enjoys robust growth in first quarter
10. Madison asks for wireless bids; airport, downtown would be first
11. Tech Digest: Inacom, PKWare at Infosecurity, Firstlogic, Teklynx

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/ - Cytochroma today announced the appointment of...oldt will replace Mr. Ulrik Spork as the Novo A/S ...of Board members remains unchanged at six members.... to the board and look forward to benefiting from ...s to make progress in becoming a leading CKD-focus...
(Date:11/24/2009)...e-FirstCall/ -- IES (Nasdaq: IESC ), a leading na...ystems and services for the commercial, industrial... commercial business group has been awarded a cont...rical systems for the Level 4 bio-safety lab (BSL-...esearch Institute of Infectious Diseases (USAMRIID...
(Date:11/24/2009)...land, November 24 deCODE...at it has received notice from,the Nasdaq Stock Ma...ll be,suspended as of November 30, 2009 and a Form...ange Commission, which will remove deCODE,s common...files an appeal to the Nasdaq,Listing Qualificatio...
(Date:11/24/2009)... NeurogesX, Inc. (Nasdaq:...eveloping and commercializing novel pain managemen... President and Chief Executive Officer, is schedul...lth Care Conference, to be held December 1-2, 2009...k. ,, Mr. DiTonno and Stephen Ghiglieri, Chief...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...orce reduction, NEW YORK, April 4, 2008 Keryx,Bi...that it is implementing a,strategic restructuring ...,development efforts. The plan, which was prompted...SUN-MICRO Phase 3 clinical trial of Sulonex(TM),(s...hy, and subsequent,decision by the Company to term...
...otech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: A... device company, announced today that the first Ne...c.,s Zilver(R) PTX(TM) drug-eluting,peripheral ste...in February,2008. The Zilver PTX is the world,s fi...ease (PAD) and was recently released for sale in c...
...Biomolecular Sciences 14th ...008 Cellix Ltd., an,international provider of mic...fesciences, announces today its worldwide launch o...esearchers to execute physiologically,relevant flo...n cells to an,endothelial cell monolayer. Dr. Kate...
Other Biology Technology:Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan 2Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan 3Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan 4Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand 2Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand 3Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand 4Cellix Ltd. Launches VenaEC Biochip for Flow-based Cell-adhesion Assays 2
(Date:11/25/2009)...Ga. Bacteria don,t have easy lives. In addition t...they have natural enemies called bacteriophages, v...two days. , Still, bacteria and another class o...in extreme environments such as deep-sea volcanic ...e they have a built-in defense system that helps p...
(Date:11/25/2009)... course of a lifetime, the heart pumps some 250 mi...er to do this, the muscle fibers of the heart have...d by Dr. Wolfgang Rottbauer, vice chair of the Dep...ospital (Chairman: Prof. Dr. H. A. Katus), has dis...ility of the smallest muscular unit, the sarcomere...
(Date:11/24/2009)...s Research Institute (LRI) today named 12 new gran...illion, recognize innovative work across a broad s...heir creativity, novelty, and potential to drive s...and cure the complex disease of systemic lupus. ,...upus researchers across the nation and include int...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 1PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 2PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 3PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 4Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 1Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 2Learn Your Way to Success 57316 1Learn Your Way to Success 57316 2Learn Your Way to Success 57316 3
...ence University researchers have identified some o... damage caused by multiple sclerosis (MS), complic...conditions. The findings offer important clues abo...nd suggest ways that at least some forms of brain ...d in the August edition of the scientific journal ...
...l babies -- 499,008 infants -- were born premature...ng to the report released by the National Center f...ercent (or about 480,000 babies) in 2002 -- and an...ment began tracking premature births in 1981. The ... every year since then except for slight dips in 1...
...versity of North Carolina at Chapel Hill School of...cer Center have identified a protein that may inhi..., CIB1, or calcium and integrin-binding protein 1,...od platelet protein that may play a role in clotti...ary of cellular functions that allow processes suc...
Other Biology News:Molecular Partners Required For Appropriate Neuronal Gene Repression 2Molecular Partners Required For Appropriate Neuronal Gene Repression 3Molecular Partners Required For Appropriate Neuronal Gene Repression 4UNC scientists discover new role for protein as fundamental inhibitor of cell movement 2
...oresearch: Developed for a wide range of bioanalyt...ience in Luminescence Spectroscopy • Automate...graphic gratings for reduced stray light • Ve...ed Xenon lamp reduces photo bleaching • Large...
...ys contain 60 rabbit tissue samples arrayed on Sup...ins 4 unstained slides and 1 hematoxylin and eosin...e contains 15 different tissues from 4 rabbit orga... Each tissue sample (or core) is 1.5 mm in diamete...
...lla typhimurium The genus Salmonella is a member ...posed of Gram-negative bacilli that are facultativ... major antigens; the "H" or flagellar antigen (pha... LPS moiety) and the "Vi" or capsular antigen (ref...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, CD from PerkinElmer
Biology Products: